Summary
We report the clinical and molecular findings in a patient with a mild form of recessive dystrophic epidermolysis bullosa (RDEB) and aortic insufficiency. To our knowledge, this is the first report of association between RDEB and abnormalities of the aortic valve. Analysis of the COL7A1 gene has revealed two new mutations, a 20-bp duplication and a splice-site mutation. These findings support the recessive inheritance of the moderately severe cases of mild RDEB.
Report
Dystrophic epidermolysis bullosa (DEB) results from mutations in the COL7A1 gene on chromosome 3p, which encodes type VII collagen, the major component of anchoring fibrils. The site and specific nature of the underlying mutations determine the clinical phenotype, which ranges widely from a relatively mild disorder, typically inherited autosomal dominantly (DDEB), to a severe, mutilating condition, inherited autosomal recessively (RDEB). Over 100 distinct mutations within the two non-collagenous domains, NC1, NC2, and the helical domain of COL7A1 have been identified in DEB patients, 1 and in the majority of cases, the mutations have been specific to individual families, with only a few reported cases of recurrent mutations. 1 2 3 The correlation between the mutations and the observed clinical phenotypes is still emerging.
Probands with dominant DEB, characteristically have a glycine substitution mutation on one allele, while patients with the most severe type of RDEB have premature termination codon (PTC) mutations in both alleles of COL7A1 resulting in a complete lack of anchoring fibrils and collagen VII.
Within the dominant and recessive forms of DEB, there is another sub-group of patients in which the affected individuals have a relatively mild phenotype, the parents appear unaffected, and the family history is negative for blistering disease. These so called "sporadic" cases of DEB were previously thought to have a new dominant DEB mutation, however, many patients in this group are now known to have a mild, recessive form of DEB. 4 In the mild forms of RDEB, at least one of the COL7A1 alleles typically contains a missense mutation, which renders it capable of producing full-length, albeit functionally imperfect, type VII collagen polypeptides. 5 The other allele can contain a PTC, a second missense mutation, an in-frame deletion or a splice site mutation. As a result of this combination of mutations, mutant full-length type VII collagen molecules may be able to assemble into a small number of poorly functioning anchoring fibrils. The resulting attachment structures, though weak, are present, which accounts for the milder phenotype observed in these forms of RDEB.
common complications include nutritional deprivation secondary to severe mucous membrane lesions leading to esophageal strictures and scarring. Dental caries are also frequently observed. Chronic anemia due to increased blood loss from the skin and gastrointestinal tract, coupled with decreased oral intake often results in continuous iron therapy supplemented by blood transfusions. Cutaneous carcinomas, particularly squamous cell carcinoma, have also been associated with RDEB.
Although far less commonly observed, certain cardiac conditions have been reported in patients with RDEB. Several cases of dilated cardiomyopathy in children with RDEB have been described. 6 7 8 In addition, mitral valve prolapse, which has a known association with several connective tissue disorders, has also been reported in two patients with RDEB. 9 10 The common pathological mechanism between the valvular anomaly and RDEB is thought to be due to an abnormality of collagen metabolism. The proband reported here is a 25-year-old male who is one of three siblings born to non-consanguineous, clinically unaffected parents. There was no history of dermatological disease in the family. Clinical findings in the patient included erosions and atrophic scarring in sites of previous trauma, such as bilateral knees, shins and heels.
Complete nail dystrophy was noted, as was pseudosyndactyly of both hands (Fig. 1 ). In addition, the patient had a history of chronic, progressive aortic regurgitation secondary Previous studies have suggested that an underlying etiology for aortic valvular degeneration may be defective synthesis of collagen or elastic fibers, lending support to a possible link with EB. 11 Furthermore, in a recent case report, a Japanese EB patient with severe mitral regurgitation was shown to have similar microscopic myxomatous changes of the valve to that seen in our patient. These authors suggest that an abnormality in collagen metabolism may play a role in the development of valvular degeneration and EB. 10 Further studies are necessary to determine whether a true relationship between these conditions exists, and if so, what common mechanisms and factors influence their development.
In order to search for mutations in the COL7A1 gene, we used a combined strategy of heteroduplex analysis and direct PCR sequencing. Genomic DNA was isolated from peripheral blood lymphocytes of the proband using PureGene DNA Isolation Kit (Gentra Systems, Minneapolis, MN) and used as a template for PCR amplification. 8µl of the PCR product was prepared for heteroduplex analysis using (Fig. 2) . To verify the duplication mutation, we subcloned the PCR product corresponding to exons 22-24 using the TOPO TA Cloning Kit (Invitrogen, Carlsbad, CA). We sequenced a total of 7 clones, corresponding to 2 wild type and 5 mutant alleles. To verify the splice site mutation, we used a mismatched PCR strategy, with the following primers: The majority of the COL7A1 PTC mutations that have been studied thus far at the mRNA level show marked COL7A1 mRNA decrease consistent with nonsense-mediated mRNA decay. 12 However, aberrant mRNA splicing around exon 23 is another possible consequence of the mutation found in this patient. In a previous study, a 16-bp intraexonic deletion in exon 87 of COL7A1 in a family with DDEB was identified, and predicted to generate a frameshift mutation and a downstream PTC. 13 Although the deletion did not disrupt any consensus splicing sequences, the mutation resulted in exon skipping and the subsequent restoration of the reading frame, instead of the expected generation of a PTC.
The second mutation observed in our patient, an A-to-G transition, occurred at position +4 of the 5' donor site of intron 64, within the central collagenous domain of the type VII collagen polypeptide. An A-to-G transition affecting the same position in the 5' splice site has previously been reported in the beta-spectrin gene where it lead to skipping of an exon, a shift in the reading frame and a PTC within one amino acid residue of the novel sequence. 14 More recently, an A-to G transition at position +4 within the 5' splice site has been described in intron 87 of COL7A1 in a patient with the Hallopeau-Siemans variant of RDEB, where it also lead to a PTC. 15 To our knowledge, this is the first incidence of this mutation in the COL7A1 gene.
Because this mutation occurs within the 5' donor splice site, its consequence is at the transcriptional level. To compare the splice sites from the wild-type and mutant sequences, we calculated their consensus values according to Shapiro and Senapathy. 16 In this procedure, splice sites are scored relative to the frequency with which the same bases have been found in 542 normal splice sites of primate genes. The splice-site score for the wild-type 5' donor splice site of intron 64 is 83.21% and for the mutated form of the 5' donor splice site of intron 64 is 72.45% (a sequence identical to the consensus gives a 100% score). This could result in decreased efficiency of the splicing apparatus leading to lower levels of the expected mRNA transcript. This would explain the lack of phenotype in the parent from whom this mutant allele was inherited, as well as the relatively mild phenotype of the proband despite his recessive condition.
On the other hand, the single base pair substitution could potentially result in an aberrant splicing pattern, leading to the complete skipping of exon 64, the retention of intron 64, or the activation of cryptic splice sites in the region.
In conclusion, this case report exemplifies the notion that identification of disease causing mutations can be a valuable tool in the characterization of the functional domains of the encoded proteins, and may have important implications for understanding the complex genotype-to-phenotype correlations of EB and other heritable diseases. 
